ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide ; volume:12 ; number:1 ; day:3 ; month:8 ; year:2022 ; pages:1-15 ; date:12.2022
Scientific reports ; 12, Heft 1 (3.8.2022), 1-15, 12.2022
- Urheber
-
Raghava Kurup, Reshma
Oakes, Eimile K.
Vadlamani, Pranathi
Nwosu, Obi
Danthi, Pranav
Hundley, Heather A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-17559-4
- URN
-
urn:nbn:de:101:1-2022101322533964504972
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raghava Kurup, Reshma
- Oakes, Eimile K.
- Vadlamani, Pranathi
- Nwosu, Obi
- Danthi, Pranav
- Hundley, Heather A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
KLF6 depletion promotes NF-κB signaling in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Accelerated hyperfractionation plus temozolomide in glioblastoma
Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
KLF6 depletion promotes NF-κB signaling in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Accelerated hyperfractionation plus temozolomide in glioblastoma
Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
KLF6 depletion promotes NF-κB signaling in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Accelerated hyperfractionation plus temozolomide in glioblastoma
Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα